Bahrain officially registers the Chinese vaccine
Kuwait licenses the emergency use of the "Pfizer" vaccine against "Corona"
During the preparation of vaccine shipments at a Pfizer factory in the United States.
A.F.B.
The Kuwaiti Ministry of Health issued a license to use the emergency use of the "Pfizer - Biontech" vaccine against the emerging corona virus, while the National Authority for Regulating Professions and Health Services in Bahrain announced, in a statement yesterday, its approval of the official registration of the anti-Corona virus vaccine produced by the Chinese pharmaceutical company Sinopharm.
The Assistant Undersecretary for Drug and Food Control Affairs at the Kuwaiti Ministry of Health, Dr. Abdullah Al-Badr, announced that the Ministry had issued an emergency use license for the "Pfizer - Biontech" vaccine. The Vegetarian and Public Health Administration to evaluate and record vaccines and vaccines.
He added that the decision came after an extensive review by the technical committee of all scientific data and reports, where the committee conducted a comprehensive evaluation of safety, efficacy and quality information, and also reviewed the results of clinical studies concerned with the effectiveness and safety of the vaccine, in addition to verifying quality reports and evaluating product stability studies, and making sure of Applying the principles of good manufacturing in factories producing vaccine according to international standards, to ensure quality at all stages of manufacturing.
Al-Badr indicated that the review process also included all technical and scientific aspects, stressing that the Ministry of Health will carefully monitor the safety and safety of the vaccine after its use, in addition to the Ministry’s continued follow-up of information and data about the safety, effectiveness and quality of the vaccine locally and internationally, and taking the necessary measures to ensure the safety of citizens and residents.
In addition, the National Authority for Regulating Professions and Health Services in Bahrain announced, in a statement yesterday, its approval of the official registration of the anti-Corona virus vaccine produced by the Chinese pharmaceutical company Sinopharm.
The statement did not specify which vaccine was approved from among the two vaccines produced by Sinopharma, but it cited data from the third phase of clinical trials that showed «the effectiveness of the vaccine by 86% against infection with the Coronavirus».
The statement stated that “Bahrain has participated in clinical trials of the vaccine as part of the Campaign for Humanity, where more than 7,700 volunteers participated in the third phase trials.
The authority has previously authorized the emergency use of the vaccine.
On the tenth of this month, Bahrain said that it would provide the Corona virus vaccine free of charge to all citizens and residents.
And this month, the Kingdom authorized the emergency use of the "Pfizer-Biontech" vaccine against "Corona".
On the other hand, the member states of the Organization of Islamic Cooperation have expressed their determination to move forward in order to cooperate in the production and distribution of vaccines and medicines, and during a workshop organized and hosted by the Indonesian Food and Drug Authority, in cooperation with the OIC General Secretariat, they emphasized the importance of the need for cooperation to face the challenges. Imposed by the outbreak of the emerging corona virus.
- The countries of the Organization of Islamic Cooperation affirm their intention to cooperate in the production and distribution of vaccines and medicines.
Follow our latest local and sports news, and the latest political and economic developments via Google news